Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Cabazitaxel Overview

Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid.[1] It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.[2][unreliable source?] Cabazitaxel in combination with prednisone is a treatment option for hormone-refractor...

Read more Cabazitaxel Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Cabazitaxel Forums: RSS Feed


What is the hcpc's code for Cabazitaxel? ## I am afraid you're going to have to be little more specific. I did try a search, but such abbreviations are not universal. I did try a search, but brought up several health care organizations, so I need to know which one you are talking about. Can you please post back?


Possible Dosages for this and Related Drugs:

  • Injection: 20mg/ml(60mg/3ml), 60mg/1.5ml, 60mg/1.5ml(40mg/ml)
  • Solution: 60mg/1.5ml (40mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Cabazitaxel or a similar ingredient: (1 result)

Related Cabazitaxel Topics:

What is the hcpc's code for Cabazitaxel? ## I am afraid you're going to have to be little more specific. I did t... 1 reply

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 February 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA